Skip to main content
CriticalFDAfda-F-1565-2017LISTERIA

Cedar Crest Pirate's Bounty Ice Cream 1.5 quarts (1419 mL)

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
10,661
Recall Date
November 11, 2016
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1565-2017.

The cookie dough used in select ice creams may be contaminated with Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1565-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Cedar Crest Specialties, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1565-2017.

Cedar Crest Specialties, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Cedar Crest Specialties, Inc. Recall FAQ

Cedar Crest Specialties, Inc. is the subject of a dairy safety report: Cedar Crest Pirate's Bounty Ice Cream 1.5 quarts (1419 mL). The notice was published on November 11, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 10,661 units are potentially affected.